BridgeMD
New treatment option for Allergic Rhinitis
Official title Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project
ClinicalTrials.gov ID: NCT07419230
What this study is testing
- What it's testing
- Aaeroallergen Immunotherapy (AIT) is indicated in the treatment of allergic rhinitis and asthma, and has shown efficacy to control symptoms and induce immunomodulatory changes that support post discontinuation efficacy. Data from clinical trials provides founding for its efficacy and safety profile, but the therapy needs to be withheld for a minimum of 3 years, with modalities that imply daily or near daily administration of a sublingual extract, or subcutaneous injections, every 4 to 6 weeks.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients of any age and sex
- Patients who have received their first prescription for a new aeroallergen immunotherapy treatment as part of their routine care for allergic...
- Patients who have been prescribed only a single immunotherapy product
- Patients who have been prescribed a commercially available product, from any company, for sublingual or subcutaneous administration
- Patients who have provided the first photograph of the product for which they are entering the study
You likely can't join if
- Patients receiving AIT prescription for asthma only, and do not suffer allergic rhinitis
- Administration routes other than subcutaneous or sublingual
- Patients receiving AIT prescription for other indications, e.g., food or hymenoptera allergies
- Patients who have received immunotherapy in the last 3 years or are currently undergoing treatment with an AIT product other than the one being...
- Patients who have received prescription for two or more different immunotherapy products simultaneously
The study team makes the final eligibility decision.
Where it's taking place
- Madrid, Madrid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madrid, Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.